Your browser doesn't support javascript.
loading
Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling.
Kerdivel, G; Chesnais, V; Becht, E; Toma, A; Cagnard, N; Dumont, F; Rousseau, A; Fenaux, P; Chevret, S; Chapuis, N; Boeva, V; Fridman, W H; Fontenay, M; Kosmider, O.
Afiliação
  • Kerdivel G; Institut Cochin, Department Development, Reproduction, Cancer, Paris, France.
  • Chesnais V; Institut National de la Santé et de la recherche médicale INSERM U1016, Paris, France.
  • Becht E; Centre National de la recherche scientifique CNRS UMR8104, Paris, France.
  • Toma A; Université Paris Descartes, Paris, France.
  • Cagnard N; Team Computational (Epi-)Genetics of Cancer, Paris, France.
  • Dumont F; Institut Cochin, Department Development, Reproduction, Cancer, Paris, France.
  • Rousseau A; Institut National de la Santé et de la recherche médicale INSERM U1016, Paris, France.
  • Fenaux P; Centre National de la recherche scientifique CNRS UMR8104, Paris, France.
  • Chevret S; Université Paris Descartes, Paris, France.
  • Chapuis N; Team Normal and pathological hematopoiesis labeled Ligue nationale contre le cancer, Paris, France.
  • Boeva V; Université Paris Descartes, Paris, France.
  • Fridman WH; INSERM UMR_S1138, Cancer, Immune controls and Escape, Cordeliers Research Center, Paris, France.
  • Fontenay M; Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Kosmider O; Assistance Publique-Hôpitaux de Paris, Service d'hématologie clinique et Thérapie Cellulaire, Hôpital Henri-Mondor, Créteil, France.
Leukemia ; 32(2): 558-562, 2018 02.
Article em En | MEDLINE | ID: mdl-28972593

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Síndromes Mielodisplásicas / Cromossomos Humanos Par 5 / Lenalidomida Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Síndromes Mielodisplásicas / Cromossomos Humanos Par 5 / Lenalidomida Tipo de estudo: Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França